Unresectable Gallbladder Cancer Completed Phase 1 Trials for Cisplatin (DB00515)

IndicationStatusPhase
DBCOND0028792 (Unresectable Gallbladder Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00949949Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard TherapyTreatment